Showing results (301-310 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|July 20, 2026
Comparative bioavailability of a novel fixed-dose combination of ticagrelor and acetylsalicylic acidSusana Tera-Ponce, Perla E Castañeda-Tera, Elva J García-Real, et al.
Clinical Pharmacology in Drug Development|April 15, 2017
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to DateLanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini
Clinical Pharmacology in Drug Development|April 20, 2026
Effects of Cedirogant on the Pharmacokinetics of Sensitive Cytochrome P450 Probe SubstratesRonilda D'Cunha, Yuli Qian, Shuai Hao, et al.
Clinical Pharmacology in Drug Development|March 23, 2026
Effect of High-Fat Diet on Pharmacokinetics and Incidence of Adverse Reactions of Tacrolimus in Healthy Chinese ParticipantsXiufang Zhu, Lingxue Shi, Lan Yang, et al.
Clinical Pharmacology in Drug Development|April 30, 2026
Ethnic Bridging of Votoplam, a HTT Gene Splicing Modifier, Using Pharmacokinetic Comparison Between Caucasian and Japanese SubjectsLucy Lee, Amy-Lee Richards, Prachi Anand, et al.
Clinical Pharmacology in Drug Development|April 24, 2026
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Luseogliflozin (TS-071) in Japanese Children and Adolescents With Type 2 Diabetes: A Multicenter, Open-Label, Parallel-Group Phase 1 StudyToru Kikuchi, Hidefumi Nakamura, Hideo Umeuchi, et al.
Clinical Pharmacology in Drug Development|August 17, 2026
Bioequivalence Study of Two Ibuprofen Arginine Formulations in Healthy Chinese Subjects Under Fed ConditionsYiyang Ying, Chunqi Huang, Li Xu, et al.
Clinical Pharmacology in Drug Development|September 3, 2026
Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy AdultsSunil Soitawala, Hiren Prajapati, Hiren Mehta, et al.
Clinical Pharmacology in Drug Development|September 1, 2026
An Open-Label Study Investigating the 5-HT2A Receptor Occupancy of Remlifanserin (ACP-204) With the PET Radioligand [18F]Altanserin in Healthy Male ParticipantsEthan S Burstein, Christine Sandiego, Brian Raether, et al.
Clinical Pharmacology in Drug Development|September 10, 2026
A Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HP501 in Male Chinese Gout Patients with HyperuricemiaLongxia Chen, Ruilin Ding, Yuanwei Chen, et al.
Pageof 135